Skip to content

Author

Roberto Bava

We have 4 of 52 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Sublethal Pesticide Effects, Synergistic Interactions, and Resilience Strategies in Honey Bees (Apis mellifera): A Narrative Review.

Pesticide exposure at chronic, field-realistic doses represents a major driver of honey bee colony weakening through sublethal and synergistic effects. This narrative review synthesizes evidence from 2010 to 2025 on neurophysiological, immunological, and behavioral impacts of major insecticide classes, with emphasis on...

Roberto Bava, F. Castagna, S. Ruga et al. · 0 citations
Open access Aug 2026

Therapeutic potential of calabrian Citrus essential oils as sustainable anthelmintics against Haemonchus contortus and Trichostrongylus colubriformis in sheep: In vitro assessment.

This study provides the first systematic evidence for in vitro anthelmintic activity of five Calabrian Citrus EOs against key stages of H. contortus and T. colubriformis, suggesting that Calabrian Citrus EOs warrant further investigation as locally sourced, sustainable anthelmintic candidates for integrated parasite ma...

Roberto Bava, F. Castagna, Carmine Lupia et al. · 0 citations
Review Sep 2026

Protecting pollinators: moving towards an ecologically integrated risk assessment framework.

The current environmental risk assessment framework for pesticides remains anchored to inadequate metrics and approaches. Although regulatory bodies incorporated chronic toxicity studies and developed advanced guidance, critical gaps in implementation undermine their effectiveness. Among these gaps are 1) continued pri...

F. Castagna, S. Ruga, Roberto Bava et al. · 0 citations
Review Open access Aug 2026

Plant-Derived Compounds as Antibiotic Adjuvants Against Drug-Resistant ESKAPE Pathogens: Mechanisms of Action, Synergistic Strategies, and Translational Challenges

Plant-derived antibiotic adjuvants represent a promising strategy to combat multidrug-resistant ESKAPE pathogens, however, greater emphasis on translational research, standardized methodologies, and clinically relevant experimental models is required to facilitate their development toward therapeutic applications.

S. Ruga, Elisa Matarese, F. Castagna et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.